Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-ppcb
/
Propanc Biopharma Ord Shs
PPCB
Add to Watchlist
1.440
USD
-0.060
-4.00%
Market hours (ET)
Quotes delayed by 15 min
USD
0.000
Pre-market (ET)
19.19M
Market Cap
0.00
P/E TTM
Propanc Biopharma Ord Shs
1.440
-0.060
-4.00%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Thu, May 7
Updated: Thu, May 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Nathanielsz (Sylvia)
18.18%
Kenyon (Julian Norman)
11.96%
Zelinger (Josef)
9.57%
UBS Financial Services, Inc.
0.87%
Marex Group plc
0.32%
Other
59.09%
Shareholders
Shareholders
Proportion
Nathanielsz (Sylvia)
18.18%
Kenyon (Julian Norman)
11.96%
Zelinger (Josef)
9.57%
UBS Financial Services, Inc.
0.87%
Marex Group plc
0.32%
Other
59.09%
Shareholder Types
Shareholders
Proportion
Individual Investor
40.46%
Investment Advisor
1.18%
Hedge Fund
0.20%
Venture Capital
0.11%
Other
58.05%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
4
112.11K
9.41%
--
2026Q1
7
311.50K
1.49%
-1.06M
2025Q4
4
112.11K
0.84%
-1.15M
2025Q3
4
112.11K
0.84%
-1.15M
2025Q2
1
900.01K
7.75%
+900.01K
2022Q4
1
--
0.00%
--
2022Q3
2
--
0.00%
--
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Nathanielsz (Sylvia)
3.80M
23.96%
-5.00
-0.00%
Jan 26, 2026
Kenyon (Julian Norman)
2.50M
18.71%
--
--
Jan 26, 2026
Zelinger (Josef)
2.00M
12.61%
--
--
Jan 26, 2026
Marex Group plc
65.02K
0.41%
-5.41K
-7.67%
Dec 31, 2025
Himy (Joseph)
50.00K
0.32%
--
--
Jan 26, 2026
Two Sigma Investments, LP
41.74K
0.26%
+41.74K
--
Dec 31, 2025
XTX Markets LLC
22.13K
0.14%
+22.13K
--
Dec 31, 2025
View more
Related ETFs
Name
Proportion
No Data